Navigation Links
Broccoli compound targets key enzyme in late-stage cancer
Date:12/3/2008

ced survival rates.

Elastase is an enzyme that shortens a cellular chemical, cyclin E, that is involved in controlling the cell cycle. The shortened version of cyclin E accelerates the cell cycle, making cancer cells proliferate faster. Firestone showed that I3C prevents the elastase shortening of cyclin E, thereby arresting development of breast cancer cells.

For more than 15 years, Firestone, Bjeldanes and their colleagues have studied the anti-cancer benefits of vegetables in the cabbage family that are lumped together in the genus Brassica and, because of their cross-shaped flowers, are often referred to as cruciferous vegetables.

Though the anti-cancer benefits have been recognized since the 1970s, the mechanism is only now being discovered, in part through the work of Firestone, Bjeldanes and their UC Berkeley colleagues.

"We have connected the dots on one extremely important pathway" by which indole-3-carbinol works, Firestone said.

In previous work, they found that indole-3-carbinol interferes with more than cell proliferation. It also disrupts the migration and alters adhesion properties of cancer cells, as well as counteracts the survival ability of cancer cells, all of which are implicated in cancer cell growth. To have such broad downstream effects, I3C must act at the beginning of a major cellular pathway, Firestone said. The newly reported research pins this activity to elastase and its effect on cyclin E.

Bjeldanes noted that I3C is available as a supplement and is a preferred preventative treatment for recurrent respiratory papillomatosis, a condition involving non-malignant tumors of the larynx. Improved versions of the chemical could thus help treat cancers other than those of the breast and prostate.

Graduate student Ida Aronchik and recent Ph.D. recipient Hanh H. Nguyen, along with colleagues in the Firestone and Bjeldanes labs, have already chemically modified I3C and boosted its act
'/>"/>

Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Broccoli sprout-derived extract protects against ultraviolet radiation
2. Broccoli May Help Fight Skin Cancer
3. Blackberries, Broccoli Sprouts Battle Cancer
4. Broccoli Sprout Extract Hinders Bladder Cancer Development
5. Broccoli Compound May Help COPD Patients
6. Coloring Compound in Fruits, Veggies May Cut Colon Cancer Risk
7. Sugary Sodas High in Diabetes-Linked Compound
8. Red wine compound shown to prevent prostate cancer
9. CutisPharma Selected by Medicine Shoppe International as Preferred Vendor for Unit-of-Use Compounding Kits
10. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
11. VioQuest to Present Data on Oncology Compounds VQD-002 and Lenocta(TM) at AACR-NCI-EORTC International Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:So Many Nursing Scrubs, So Many Decisions: blue sky scrubs Offers Tips on How to Find That Perfect Set of Medical Scrubs 2Health News:So Many Nursing Scrubs, So Many Decisions: blue sky scrubs Offers Tips on How to Find That Perfect Set of Medical Scrubs 3Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 2Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 3Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 4Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 5Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 6Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 7Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 8Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 9Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 10Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 11Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 12Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 13Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 14Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 15Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 16Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 17Health News:BioMed Realty Trust Reports Fourth Quarter and Full-Year 2008 Financial Results 18Health News:Boys and Girls Clubs of Central Oregon Get $10K Regence Grant 2Health News:2008 AAAS Newcomb Cleveland Prize recognizes science paper on limb regeneration in newts 2Health News:Long and Lovely Lashes by LATISSE(TM) Now Available Through Plastic Surgery Services of Fredericksburg 2Health News:Tuba Spells Trouble for Young Musician 2
Breaking Medicine Technology:VidaySalud.com(TM) Reaches 1,000,000 Page Views In its First Six Months of Operation 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 2Elusys Presents Data From Anthim(R) Anthrax Anti-Toxin Studies at the HHS Stakeholders Workshop 2009 & BARDA Industry Day 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3AMERIGROUP Corporation Names Two New Executives 58138 1AMERIGROUP Corporation Names Two New Executives 58138 2AMERIGROUP Corporation Names Two New Executives 58138 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 1Bubble Trouble Team Hits the Lab for Good Hygiene 58133 2Bubble Trouble Team Hits the Lab for Good Hygiene 58133 3Bubble Trouble Team Hits the Lab for Good Hygiene 58133 4Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 1Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 2Sinobiopharma Reports Highlights From Audited Financial Results for the Fiscal Year Ended May 31 2009 14227 3
Other Medicine Technology:New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 2New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 3New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 4New Study Shows Doxorubicin Plus Paclitaxel Followed by Weekly,Paclitaxel as Adjuvant Therapy for High Risk Breast Cancer,Warranted in Place of Doxorubicin Plus Cyclophosphamide Followed by,Paclitaxel 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 2Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 3Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 4Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 5Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 6Data Demonstrated Metastatic Melanoma Response to Investigational,Immunotherapy Ipilimumab 7